0001209191-22-048195.txt : 20220831 0001209191-22-048195.hdr.sgml : 20220831 20220831200807 ACCESSION NUMBER: 0001209191-22-048195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220812 FILED AS OF DATE: 20220831 DATE AS OF CHANGE: 20220831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVIN ARTHUR A CENTRAL INDEX KEY: 0001181556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39321 FILM NUMBER: 221219262 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avidity Biosciences, Inc. CENTRAL INDEX KEY: 0001599901 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461336960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE STREET 2: SUITE 125 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-401-7900 MAIL ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE STREET 2: SUITE 125 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Avidity Biosciences LLC DATE OF NAME CHANGE: 20161227 FORMER COMPANY: FORMER CONFORMED NAME: Avidity NanoMedicines LLC DATE OF NAME CHANGE: 20140211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-12 0 0001599901 Avidity Biosciences, Inc. RNA 0001181556 LEVIN ARTHUR A C/O AVIDITY BIOSCIENCES, INC. 10578 SCIENCE CENTER DRIVE, SUITE 125 SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2022-08-12 4 M 0 14003 0.53 A 15333 D Common Stock 2022-08-12 4 S 0 14003 22.00 D 1330 D Common Stock 2022-08-15 4 M 0 27740 0.53 A 29070 D Common Stock 2022-08-15 4 M 0 34758 1.24 A 63828 D Common Stock 2022-08-15 4 S 0 62498 22.1182 D 1330 D Common Stock 2022-08-16 4 M 0 3499 1.24 A 4829 D Common Stock 2022-08-16 4 S 0 3499 22.0798 D 1330 D Common Stock 273872 I By family trust Stock Option (Right to Buy) 0.53 2022-08-12 4 M 0 14003 0.00 D 2027-08-28 Common Stock 14003 27740 D Stock Option (Right to Buy) 0.53 2022-08-15 4 M 0 27740 0.00 D 2027-08-28 Common Stock 27740 0 D Stock Option (Right to Buy) 1.24 2022-08-15 4 M 0 34758 0.00 D 2030-02-18 Common Stock 34758 131922 D Stock Option (Right to Buy) 1.24 2022-08-16 4 M 0 3499 0.00 D 2030-02-18 Common Stock 3499 128423 D The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.47.The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.30.The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On March 18, 2021, the Reporting Person filed a Form 4 reporting the total number of shares indirectly owned through a family trust. These indirect holdings were inadvertently omitted from the Reporting Person's subsequent reports on Form 4 filed on June 16, 2021, June 22, 2021, June 28, 2021 and November 22, 2021. This option is exercisable as to vested and unvested shares. The option was granted on August 29, 2017 and 1/48th of the shares subject to the option vest monthly. 25% of the shares subject to the option vested on February 19, 2021, and 1/48th of the shares subject to the option will vest monthly thereafter. On June 11 2020, the Reporting Person filed a Form 3 which inadvertently overreported the number of options under this option grant due to a typographical error. The aggregate number of options beneficially owned has been updated in this Form 4 to reflect the total number of options held by the Reporting Person following the transactions reported on this Form 4 and the Reporting Person's previously filed reports. /s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact 2022-08-31